Literature DB >> 8090223

Activation of p70/p85 S6 kinase by a pathway independent of p21ras.

X F Ming1, B M Burgering, S Wennström, L Claesson-Welsh, C H Heldin, J L Bos, S C Kozma, G Thomas.   

Abstract

The enzymes p70s6k and p85s6k are two isoforms of the same kinase and are important in mitogenesis. Both isoforms are activated by a complex phosphorylation event and lie on a common signalling pathway, distinct from that of the p42mapk/p44mapk kinases. Activation of p42mapk/p44mapk is triggered by sequential activation of the GDP-GTP exchange factor Sos, the GTP-binding protein p21ras, and protein kinases p74raf and p47mek (refs 7-10). As p21ras transformed cells have increased S6 phosphorylation, we tested whether the p70s6k/p85s6k signalling pathway bifurcates between p21ras and p42mapk/p44mapk. We found that mutants of p74raf and p21ras blocked activation of epitope-tagged p44mapk but not epitope-tagged p70s6k. Moreover, in cells expressing human platelet-derived growth factor receptors lacking the kinase-insert domain, the growth factor activates p21ras but not p70s6k/p85s6k. The critical autophosphorylation site for p70s6k/p85s6k activation within this domain is a tyrosine at residue 751. Our results show that the p70s6k/p85s6k signalling pathway is independent of p21ras, that it bifurcates from the p21ras pathway at the receptor, and that it is initiated by autophosphorylation at a specific site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090223     DOI: 10.1038/371426a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  56 in total

Review 1.  Phosphatidylinositol 3' kinase signaling in mammary tumorigenesis.

Authors:  M P Scheid; J R Woodgett
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

2.  Mitogenic signalling by delta opioid receptors expressed in rat-1 fibroblasts involves activation of the p70s6k/p85s6k S6 kinase.

Authors:  M A Wilson; A R Burt; G Milligan; N G Anderson
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k.

Authors:  S R von Manteuffel; P B Dennis; N Pullen; A C Gingras; N Sonenberg; G Thomas
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.

Authors:  D Graus-Porta; R R Beerli; J M Daly; N E Hynes
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

5.  SKIP negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation.

Authors:  Takeshi Ijuin; Tadaomi Takenawa
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

6.  Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation.

Authors:  L A Cass; S A Summers; G V Prendergast; J M Backer; M J Birnbaum; J L Meinkoth
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

7.  Macrophage differentiation increases expression of the ascorbate transporter (SVCT2).

Authors:  Huan Qiao; James M May
Journal:  Free Radic Biol Med       Date:  2009-02-27       Impact factor: 7.376

8.  Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase.

Authors:  H Shima; M Pende; Y Chen; S Fumagalli; G Thomas; S C Kozma
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

9.  Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.

Authors:  A E Lenferink; R Pinkas-Kramarski; M L van de Poll; M J van Vugt; L N Klapper; E Tzahar; H Waterman; M Sela; E J van Zoelen; Y Yarden
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

10.  Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras.

Authors:  Mandayam O Nandan; Hong S Yoon; Weidong Zhao; Lillian A Ouko; Sengthong Chanchevalap; Vincent W Yang
Journal:  Oncogene       Date:  2004-04-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.